Status:
COMPLETED
Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19
Lead Sponsor:
Stanford University
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
National Cancer Institute (NCI)
Conditions:
Coronavirus
Eligibility:
All Genders
2+ years
Brief Summary
The purpose of this study is to test over time immunity to SARS-CoV-2, a recently identified coronavirus responsible for the 2019 world-wide pneumonia outbreak known as COVID-19. Adults and children d...
Eligibility Criteria
Inclusion
- Adults (18 years and older) and children with confirmed COVID-19 (RT-PCR diagnosis).
- Adults (18 years and older) and children without COVID-19 for controls (who test negative for COVID-19 but may have viral symptoms)
Exclusion
- Patients with special risks attendant to venipuncture will be excluded.
Key Trial Info
Start Date :
April 8 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2022
Estimated Enrollment :
316 Patients enrolled
Trial Details
Trial ID
NCT04373148
Start Date
April 8 2020
End Date
May 31 2022
Last Update
June 15 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford Health Care - ValleyCare
Pleasanton, California, United States, 94588
2
Stanford University, Hospital, and Clinics
Stanford, California, United States, 94305